Recently there has been major interest in the integrin ␣v␤3 because of its role in angiogenesis and apoptosis (20, 21 ). An initial step in these processes often involves the binding of a matrix protein to ␣v␤3. There has been extensive work on the role of TSP on cell attachment involving ␣v␤3; however, little is known about the signal transduction events (4, 7, 18) . Increasing evidence from various groups clearly shows that the role of integrins extends beyond the binding of ligands or matrix proteins (22) (23) (24) . The binding of various matrix proteins to their receptors, especially integrins, often triggers different signals such as tyrosine phosphorylation and changes in intracellular pH or Ca 2ϩ (25) (26) (27) . These outside-in signaling events serve as important regulatory mechanisms to mediate subsequent molecular events such as modulation of integrin affinity (28, 29) or gene transcription (30) .
In this study, we investigated the role of TSP in triggering Ca 2ϩ mobilization in a lung fibroblast cell line, IMR-90. In addition, we also used known inhibitors of both the cell binding domains and the receptors of TSP to elucidate the structural basis of TSP-induced transmembrane signaling. The findings suggest that intact TSP can mediate Ca 2ϩ mobilization via both the RGD and carboxyl-terminal domains.
EXPERIMENTAL PROCEDURES
Materials-Human platelet-derived thrombospondin, TSP-1, was from Haematologic Technologies Inc. (Essex Junction, VT). Fura-2/AM ester was from Molecular Probes. Echistatin and the RFYVVMWK peptide were purchased from Bachem (King of Prussia, PA). Peptides GRGDSP, GRGESP, and CSVTCG were synthesized by Dr. Ram Seetharam of the DuPont Merck Pharmaceutical Co. Monoclonal antibodies used in this study include anti-␣v␤3 (LM609, Chemicon, CA), anti-␣v␤5 (P1F6, Becton Dickinson), and anti-CD36 (FA6.152, Immunotech, ME). Anti-TSP antibodies, C6.7 and A4.1, were from Life Technologies, Inc. Anti-integrin-associated protein antibody, B6H12, was a gift from Dr. Eric Brown (Washington University, St. Louis) (31) . All antibodies were purified IgG protein except C6.7 and A4.1 which were in ascites form. Lung fibroblast cell line IMR-90 (American Type Culture Collection) was grown in Dulbecco's modified Eagle's medium with 10% fetal bovine serum (Life Technologies, Inc.). To minimize the effect of cell passage, cells were used between passages 12 and 15 and were in culture 4 -6 days before each experiment.
Cell Surface Expression of Thrombospondin Receptors-Expression of thrombospondin receptors on IMR-90 was determined by indirect immunofluorescence and analyzed by flow cytometry. IMR-90 were removed from culture flasks using trypsin/EDTA. Cells were washed and resuspended in Ca 2ϩ -containing phosphate-buffered saline. They were then incubated with saturating amounts of primary antibodies followed by phycoerythrin-conjugated goat anti-mouse IgG F(abЈ) 2 (Chemicon). Labeled cells were analyzed on a FACScan flow cytometer (Becton Dickinson).
Indirect Immunofluorescence Microscopy-IMR-90 fibroblasts were cultured in chamber slides using the same conditions described above. For immunofluorescence staining, cells were washed with phosphatebuffered saline with 0.15% bovine serum albumin and fixed in 4% paraformaldehyde/phosphate-buffered saline for 15 min. The slides were incubated overnight at 4°C with the primary antibody, LM609 (2 g/ml), followed by a 1:400 dilution of Cy3-conjugated goat anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) for 2 h at 4°C. To induce integrin clustering, fibroblasts were pretreated with * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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TSP for 1-2 min and fixed immediately with paraformaldehyde followed by antibody staining. Cells were visualized using a 63ϫ/N.A. 1.4 oil immersion objective on a Zeiss Axiovert microscope (Carl Zeiss). Fluorescence images were collected through a dichroic mirror and 580 nm long pass filters onto a CCD camera (Zeiss ZVS-47DEC). Images were stored and processed on a Macintosh workstation using Oncor Image software (Oncor Imaging, Gaithersburg, MD) and Adobe Photoshop v.3.
Intracellular Calcium [Ca 2ϩ ] i Measurements-Intracellular calcium in single cells was measured using Fura-2 ratio imaging. Briefly, IMR-90 fibroblasts were grown on fibronectin-coated glass coverslips and loaded with 2 M Fura/AM ester for 1 h at 37°C. Cells were then washed three times with buffer containing 130 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 10 mM glucose, and 20 mM HEPES, at pH 7.4. The coverslip was mounted on the stage of a Nikon Diaphot microscope using an open coverslip chamber (Warner Instruments, Hamden, CT), and the cells (ϳ10 -20 cells per field) were visualized using a Nikon Fluor 40ϫ/N.A. 1.3 oil immersion objective. Dual excitation was provided from a 150-watt xenon arc lamp through a Ludl filter wheel system with band pass filters at 340 and 380 nm. Epifluorescence images were captured by an intensified CCD camera (QX-100, Quantex), and emitted light was collected through a dichroic mirror and a 520 nm long pass filter. The system was operated by a Dell 386 Dimension computer using the Image1/FL software (Universal Imaging Corp, West Chester, PA) for both data acquisition and analysis. The 340/380 ratio was calculated and exported to a Microsoft Excel spreadsheet, and intracellular calcium was estimated using the equation:
R max was determined by 2-4 M ionomycin (Calbiochem) and R min by 10 M EGTA. S f2 and S b2 were determined by procedures published by Grynkiewicz et al. (32) . All single-cell fluorescence recordings were done at room temperature with background subtracted. Background was determined using a field on the coverslip with no cells. For each experiment, the responses of 5-10 individual cells were averaged. In inhibition experiments, peptides or antibodies were preincubated with cells for 2-5 min before addition of TSP. Increases in [Ca 2ϩ ] i due to TSP varied among different cell preparations in the range of 91-569 nM. To normalize for this interexperimental difference, % control or % inhibition was calculated from the TSP response of each experiment. Cell morphology was monitored by phase contrast microscopy. None of the antagonists or antibodies used in these experiments significantly affected the morphology of these cells within the time period of the experiment.
RESULTS
Addition of TSP to IMR-90 cells caused a concentration-dependent transient rise in [Ca 2ϩ ] i ranging from 55-ϳ1000 nM in Ͼ90% of the cells (Fig. 1 ). This [Ca 2ϩ ] i increase peaked within 10 -30 s and returned to resting levels after 60 -180 s depending on the concentration of TSP ( ] i increase is due to EGTA's effect on Ca 2ϩ -dependent ligand binding to TSP receptors rather than depletion of the source of Ca 2ϩ available for transmembrane fluxes (4, 33) . Chelation of Ca 2ϩ has been shown to dissociate the integrin heterodimer and alter the tertiary structure of TSP (7, 18, 34, 35 ] i (36, 37) . The IMR-90 cells express both ␣v␤3 and ␣v␤5 on their cell surface as evident from the flow cytometry data (Fig. 3) . To investigate the possibility that the TSP-induced increase in [Ca 2ϩ ] i was mediated via the ␣v integrin, the effect of an antibody to ␣v␤3 (LM609) was studied (38) . LM609, at 4 and 10 g/ml, inhibited TSP-induced increases in [Ca 2ϩ ] i by 54 and 63%, respectively (Figs. 4A and 5).
Since this Ca 2ϩ increase was apparently due to a calcium influx, we investigated further whether it was via the integrinassociated protein (IAP) which has been shown to mediate integrin-regulated Ca 2ϩ flux into cells (39) . We tested the effect of a recently described antibody to IAP, B6H12 (31), on TSPinduced increases in [Ca 2ϩ ] i . B6H12, at 4 and 10 g/ml, inhibited TSP-induced increases in [Ca 2ϩ ] i by 42% and 50%, respectively (Figs. 4B and 5). On the other hand, the TSP-induced increase in [Ca 2ϩ ] i was not inhibited by the control antibody to ␣v␤5 (Figs. 4C and 5 ). In addition, LM609 and B6H12 do not block non-TSP-, i.e. thrombin, mediated increases in [Ca 2ϩ ] i , which indicates they specifically block ␣v␤3 integrin-mediated Ca 2ϩ flux. 2 None of these monoclonal antibodies raised the baseline [Ca 2ϩ ] i at the concentrations tested. Earlier studies have reported that integrin clustering is very important in signal transduction (25, 40, 41) . Here we investigated the effect of TSP and inhibitors of the TSP-␣v␤3 interaction on integrin clustering. As shown in Fig. 6 , TSP induces significant integrin clustering in IMR-90. This is not seen in cells that were not exposed to TSP or those that were pretreated with LM609, suggesting a specific interaction between the integrin and the matrix protein.
Role of the RGD Domain in TSP-induced [Ca 2ϩ ] i IncreaseMany of the integrins, including ␣v␤3, recognize the RGD tripeptide sequence as a binding motif. The RGD domain is found in the type III calcium binding repeats and has been shown to support cell attachment. Two RGD-containing peptides, GRGDSP and echistatin, were used to test the RGD dependence of the TSP-induced increase in [Ca 2ϩ ] i . At 0.8 mM GRGDSP, the increase is inhibited by 48%, whereas the same concentration of GRGESP only inhibited 7% (Fig. 7, A and B) .
Echistatin, which is known to be a more potent integrin antagonist (42), inhibited the increase in [Ca 2ϩ ] i by 72% at 0.8 M (Fig. 7C) . Both GRGDSP and echistatin inhibit the TSP-in- 2 Data not shown. ] i increase in a concentration-dependent manner (Fig. 8) .
In ] i in 50% of the cells at 5 M, but no effect was seen at 1 M.
Role of Non-RGD Cell Binding Domains in [Ca

2ϩ
] i Increase-Since neither anti-␣v␤3 nor RGD-containing peptides can completely inhibit TSP-induced rises in [Ca 2ϩ ] i , it is possible that there may be other components that mediate the Ca 2ϩ signaling in addition to the integrin ␣v␤3. To identify the structural basis for this non-␣v␤3 component of the intracellular signaling, a series of experiments was carried out using antibodies and peptides directed to either the different cell binding domains or the receptor(s) of TSP.
One of the potential candidates is CD36, which is the receptor for the type I repeat of TSP (17) . This surface glycoprotein CD36 has been shown to mediate signal transduction in platelets by increasing [Ca 2ϩ ] i (43) . However, in this system, it is unlikely that CD36 mediates the increase in [Ca 2ϩ ] i as IMR-90 do not express CD36 on their cell surface (Fig. 3) . In addition, the peptide CSVTCG, which corresponds to the CD36 binding motif on TSP and has been shown to inhibit cell adhesion (13), did not have any effect on TSP-induced rises in [Ca 2ϩ ] i (Fig. 9) . , cells showed significant integrin clustering as indicated by the white arrows. A 2-min preincubation with 20 g/ml LM609, which prevents the interaction of ␣v␤3 with TSP, showed significantly less clustering (C). Cells incubated with isotype match antibody did not stain (not shown). The distribution of ␣v␤3 was observed using LM609 followed by Cy3-conjugated goat anti-mouse IgG as described under "Experimental Procedures" (magnification, ϫ 1000). 
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CSVTCG by itself had no effect on baseline [Ca 2ϩ ] i . Likewise, the heparin binding domain of TSP also did not seem to play a role in generating this [Ca 2ϩ ] i increase because heparin, at a concentration (100 g/ml) that had been shown to effectively block cell adhesion (15), did not inhibit TSP-induced rises in [Ca 2ϩ ] i (Fig. 9) . Another possibility is the carboxyl-terminal cell binding domain of TSP which has been described to support non-RGD-dependent cell adhesion in melanoma cell lines (14, 15) . When TSP was preincubated with C6.7, an antibody against this domain, the TSP-induced increase in [Ca 2ϩ ] i is inhibited by 50%. This suggests that part of the Ca 2ϩ signal generated by TSP may be due to the binding of the carboxyl-terminal domain to its receptor (Fig. 9 ). This effect is apparently specific to the carboxyl-terminal binding domain since antibody A4.1 (10, 44) , directed against the amino-terminal half of the central stalk region of TSP, did not block the [Ca 2ϩ ] i increase. Nonspecific antibody did not have any significant effect on [Ca 2ϩ ] i increase. Interestingly, when both LM609 (10 g/ml) and C6.7 (1:100) were used together, no synergistic or additive effect was seen. 3 It is unclear, at this point, if this is due to a lack of cooperativity of the two sites. Nevertheless, more direct evidence of the role of the carboxyl-terminal of TSP came from studies with the carboxyl-terminal domain peptide RFYVVMWK (45) . This peptide at 100 M triggered a transient increase in [Ca 2ϩ ] i that reached Ն2 M in 35% of the cells (Fig. 10) . This suggests that the carboxyl-terminal cell binding domain may mediate part of the TSP-induced rise in [Ca 2ϩ ] i . Altogether, these data indicate that intact TSP can mediate an increase in [Ca 2ϩ ] i in IMR-90 fibroblasts via at least two pathways: the RGD domain binding to the ␣v␤3 integrin and the carboxyl-terminal domain possibly binding to an unidentified receptor.
DISCUSSION
In this study we have shown that TSP, a matrix protein which binds to multiple cell surface receptors, increases [Ca 2ϩ ] i in IMR-90 fibroblasts. This increase, which is partially mediated by the RGD domain of TSP binding to the integrin ␣v␤3, is not limited to IMR-90, as we have also observed this in endothelial cells. 3 We have also shown that known inhibitors of ␣v␤3, GRGDSP peptide and echistatin, in addition to blocking TSP-induced signaling, are capable of triggering an increase in [Ca 2ϩ ] i by themselves. This suggests that RGD-containing peptides can function as both competitive antagonists and partial agonists for their receptors. This had been reported previously by several other groups; however, our threshold concentrations are much higher than those reported elsewhere (36, 37) . One possible explanation is that high concentrations of peptides or antibodies could induce clustering of integrins, which could activate the integrins and trigger transmembrane Ca 2ϩ flux not normally seen at the lower concentrations (26, 46) . This clustering is seen in the present study when ␣v␤3 integrins interact with TSP. These findings illustrate that integrin clus- 
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tering, presumably caused by multimeric interactions between the ligand and its receptors, is important in transmembrane signaling (41) . This is further supported by the observation that RGD peptide can produce an increase in [Ca 2ϩ ] i (Ͼ1 mM) in kidney epithelial cells when coupled to beads but not when it is in the soluble monomeric form (29) . In addition, earlier studies with ␤2 integrin (CD11b/CD18) demonstrate that antibodies to the ␣ and ␤ can induce Ca 2ϩ signal only if they are cross-linked (40) .
Another confounding factor is that this ligand-induced integrin signaling may be dependent on the type of cell preparation being used. Sjaastad et al. (29) have reported that soluble RGD (ϳ0.3 mM) was not able to produce an increase in [Ca 2ϩ ] i in kidney epithelial cells, whereas two other groups both observed an increase in osteoclasts at a similar concentration (36, 37) . Even within the same cell type the data are not consistent. In that regard, echistatin was shown to induce increases in [Ca 2ϩ ] i in rat osteoclasts by one group but not by the other group (36, 37) . This discrepancy indicates the complexity of ligand/integrin-mediated signaling.
Ligand-induced signaling through integrins does not follow the paradigm for traditional signaling receptors. In general, integrins differ from the known signaling receptors in their short cytoplasmic domain, lack of kinase activity, and lack of direct interaction with G-proteins (23) . In this study we have shown that the [Ca 2ϩ ] i signal triggered by the soluble matrix protein, TSP, via the integrin ␣v␤3, is dependent on extracellular calcium. The present data using EGTA or Ni 2ϩ indicates that the increase in [Ca 2ϩ ] i is due primarily to an influx of extracellular Ca 2ϩ , possibly through some type of Ca 2ϩ channel. Additional evidence supporting this hypothesis was demonstrated by our data with the antibody to IAP, B6H12, which was shown to block ϳ50% of [Ca 2ϩ ] i increase. IAP, which has been shown to be closely associated with ␣v␤3 (31), was recently shown by Schwartz et al. (39) to be required specifically for integrin-regulated Ca 2ϩ influx. This suggests that IAP may function as an integrin-associated calcium channel. Moreover, purified integrin ␣IIb␤3 was reported to function as a calcium channel when reconstituted into liposomes (47) . This suggests that the integrin itself can act as a conduit for transmembrane Ca 2ϩ flux that is distinct from the classical Ca 2ϩ channels. Taken together, it is possible that the ␣v␤3 integrin or its associated proteins, upon ligand binding, can be activated and function as a Ca 2ϩ channel for signal transduction. The present data also show that there are other components of the transmembrane Ca 2ϩ flux that are non-RGD and non␣v␤3-dependent. This notion comes from the inability of the synthetic RGD-peptide and LM609 to completely inhibit TSPinduced rises in [Ca 2ϩ ] i and is verified by the observation that an antibody to carboxyl-terminal domain, C6.7, is also able to inhibit 50% of the Ca 2ϩ signal. The carboxyl-terminal domain of TSP has been reported to support chemotaxis and cell migration (48, 49) . Further studies using the carboxyl-terminal domain peptide, RFYVVMWK, indicate that the carboxyl-terminal domain of TSP is also capable of triggering Ca 2ϩ increases by itself. Since this Ca 2ϩ increase is observed only in a subpopulation of cells, this receptor might not be present on all cells. Two possible receptors for the carboxyl-terminal binding domain have so far been identified, an 80/105-kDa complex on carcinoma cells (4) and a 52-kDa domain on K-562 cells (19) . Even if either of these receptors exists in the IMR-90, it is unclear if they are responsible for the binding of the carboxylterminal TSP fragment and the subsequent transduction of the signal across the cell membrane. The carboxyl-terminal peptide and GRGDSP trigger increases in [Ca 2ϩ ] i in the millimolar range at peptide concentrations of 0.1 and 0.8 mM, respectively.
With intact TSP, only 1 M is required to trigger similar increases in [Ca 2ϩ ] i . The main reason for this disparity in threshold concentrations is the multivalent and higher affinity binding of the multimeric matrix protein TSP versus the monovalent and lower affinity binding of the peptide fragments (41, 50) . In addition to having high affinity receptors, multimeric ligands are more effective in inducing receptor clustering as shown in the present study; together, these have been shown to work synergistically in transmembrane signaling (41) .
In addition, TSP might potentially mediate signaling via other receptors. One such TSP receptor is CD36 which was not studied here due to the lack of expression on IMR-90 fibroblasts. There is evidence from the literature that CD36 is capable of mediating signal transduction by increasing [Ca 2ϩ ] i in platelets and triggering oxidative bursts in monocytes (43, 51) . However, these two studies utilized monoclonal antibodies against CD36 to trigger the signaling events, and, therefore, it is uncertain if intact TSP or its fragments will produce similar results via CD36.
In summary, we have demonstrated that TSP can trigger transient increases in [Ca 2ϩ ] i in IMR-90 fibroblasts by increasing Ca 2ϩ influx. The response is inhibitable by specific TSP receptor antibodies indicating that this is a receptor-mediated effect. While we have shown this to occur primarily via the RGD and carboxyl-terminal domains of TSP and their corresponding receptors, we cannot rule out the possibility of the other TSP receptors as signaling molecules in other cellular systems. The data from the present study, together with previous reports, indicate that TSP can support cell attachment and signaling through its different cell binding domains (4, 7, 13, 14, 18, 45) . These observations confirm that matrix proteins, with their multiple cell binding domains, can interact with corresponding cell surface receptors to transduce signals across the cell membrane. These outside-in signaling events will be important in understanding the role TSP plays in cell attachment, migration, and proliferation.
